Table 1 Demographic and clinicopathological characteristics of the main study population
From: MMP2 and MMP7 at the invasive front of gastric cancer are not associated with mTOR expression
Parameters | Intestinal (n = 86) | Diffuse (n = 42) | Total (N = 128) | p-value | |
|---|---|---|---|---|---|
Age in years (median, IQR) | 79 (72–85) | 78 (68–84) | 78 (70–78) | 0.239 | |
Sex (male) | 61 (70.9 %) | 24 (57.1 %) | 85 (66.4 %) | 0.163 | |
T-stage | T1 | 13 (15.1 %) | 3 (7.1 %) | 16 (12.5 %) | 0.328 |
T2 | 36 (41.9 %) | 15 (35.7 %) | 51 (39.8 %) | ||
T3 | 31 (36.0 %) | 22 (52.4 %) | 53 (41.4 %) | ||
T4 | 6 (7.0 %) | 2 (4.8 %) | 8 (6.2 %) | ||
N-stage* | Positive (N1-3) | 57 (66.3 %) | 39 (92.9 %) | 96 (75.0 %) | 0.001 |
M1 | Positive (M1) | 29 (33.7 %) | 20 (47.6 %) | 49 (38.3 %) | 0.175 |
Grading* | G1 | 6 (7.0 %) | 0 (0) | 6 (4.7 %) | <0.001 |
G2 | 45 (52.3 %) | 1 (2.4 %) | 46 (35.9 %) | ||
G3 | 35 (40.7 %) | 41 (97.6 %) | 76 (59.4 %) | ||
Localisation* | Cardia | 30 (34.9 %) | 6 (14.3 %) | 36 (28.1 %) | 0.042 |
Corpus | 33 (38.4 %) | 23 (54.8 %) | 56 (43.8 %) | ||
Antrum | 23 (26.7 %) | 13 (31.0 %) | 36 (28.1 %) |